The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate.
Inspection Record
Omega Laboratories Ltd. (now Juno Pharma Canada Inc.) — Health Canada Inspection Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
The receipt, preparation, and/or handling of reagents and culture media was inadequate. The traceability, legibility, documentation, formatting, and/or the accuracy of records was inadequate.
The ongoing stability program for a drug was inadequate.
The establishment and/or the maintenance of a data governance plan was inadequate.
The investigation, handling, and/or reporting of test results that were out-of-specification was inadequate.
About this record
Extracted automatically from the document of the Health Canada inspection on 2021-12-07. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
